Laurence Katznelson, MD, Stanford University School of Medicine Disclosure: Consultant, Novartis; Speaker, Ipsen, Novo Nordisk.
Laurence Katznelson, MD received his medical degree from the University of California, Los Angeles and performed his internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania, Philadelphia. He then performed a fellowship in endocrinology and metabolism at the Massachusetts General Hospital, Boston. Dr. Katznelson is currently the Medical Director of the Pituitary Center at Stanford University Medical Center, Stanford, California. Dr. Katznelson is a Professor of Medicine and Neurosurgery at Stanford University School of Medicine. At Stanford University, he is the Program Director for the Endocrine fellowship training program. He is a member of the Editorial Board for Pituitary, and is an ad hoc reviewer for the Journal of Clinical Endocrinology and Metabolism. Dr. Katznelson is Chair of the Special Programs Committee and is a member of the Scientific and Educational Programs Core Committee in the Endocrine Society. He has served as an ad hoc member of NIH study sections. Dr. Katznelson has a long standing clinical and research interest in the pathophysiology and treatment of pituitary disease.
Paul M. Copeland, MD, Massachusetts General Hosp Disclosure: Nothing to Disclose
Paul M. Copeland, M.D. is Chief of Endocrinology at North Shore Medical Center in Salem, Massachusetts, Clinical Affiliate at the Massachusetts General Hospital, Endocrine Consultant for the MGH Weight Center, and Assistant Clinical Professor of Medicine at Harvard Medical School. He received a BA and MD from Yale University, did a Residency in Medicine at the Hospital of the University of Pennsylvania, and completed a Fellowship in Endocrinology at Massachusetts General Hospital. During the second month of his fellowship he saw three patients with incidentally discovered adrenal masses. The existing recommendation at that time, coming from the Urology literature, was for universal resection. All three patients had benign pathology and all three had minor surgical complications. This outcome led him to develop an evaluation of these masses, published in the Annals of Internal Medicine, which permitted a more selective approach that continues to be refined.